Article
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation.
Journal of cancer research and clinical oncology - 1 Jul 2023
Cambui Raylane Adrielle Gonçalves, Fernandes Fernanda Pereira, Leal Vinicius Nunes Cordeiro, Reis Edione Cristina, de Lima Dhemerson Souza, do Espírito Santo Gilmar Ferreira, Elias Rosa Maria, Pontillo Alessandra
Abstract excerpt
PURPOSE: TMEM176B was recently described as a negative modulator of Nlrp3 inflammasome activation in mice. In the mouse model, the inhibition of TMEM176B leads to an increased anti-tumoral activity which is dependent on Nlrp3. Since we have recently shown that single nucleotide variants (SNPs) in inflammasome genes, including NLRP3, significantly affect colorectal cancer (CRC) prognosis, we proposed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
